These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 23596287)

  • 1. Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.
    Ivanov S; Renneson J; Fontaine J; Barthelemy A; Paget C; Fernandez EM; Blanc F; De Trez C; Van Maele L; Dumoutier L; Huerre MR; Eberl G; Si-Tahar M; Gosset P; Renauld JC; Sirard JC; Faveeuw C; Trottein F
    J Virol; 2013 Jun; 87(12):6911-24. PubMed ID: 23596287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia.
    Paget C; Ivanov S; Fontaine J; Blanc F; Pichavant M; Renneson J; Bialecki E; Pothlichet J; Vendeville C; Barba-Spaeth G; Huerre MR; Faveeuw C; Si-Tahar M; Trottein F
    J Immunol; 2011 May; 186(10):5590-602. PubMed ID: 21490153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GP96 Drives Exacerbation of Secondary Bacterial Pneumonia following Influenza A Virus Infection.
    Sumitomo T; Nakata M; Nagase S; Takahara Y; Honda-Ogawa M; Mori Y; Akamatsu Y; Yamaguchi M; Okamoto S; Kawabata S
    mBio; 2021 Jun; 12(3):e0326920. PubMed ID: 34061598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages.
    Paget C; Ivanov S; Fontaine J; Renneson J; Blanc F; Pichavant M; Dumoutier L; Ryffel B; Renauld JC; Gosset P; Gosset P; Si-Tahar M; Faveeuw C; Trottein F
    J Biol Chem; 2012 Mar; 287(12):8816-29. PubMed ID: 22294696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
    Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
    Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.
    Brincks EL; Gurung P; Langlois RA; Hemann EA; Legge KL; Griffith TS
    J Immunol; 2011 Nov; 187(9):4581-8. PubMed ID: 21940678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteinyl Maresins Reprogram Macrophages to Protect Mice from Streptococcus pneumoniae after Influenza A Virus Infection.
    P Tavares L; Brüggemann TR; M Rezende R; G Machado M; Cagnina RE; Shay AE; C Garcia C; Nijmeh J; M Teixeira M; Levy BD
    mBio; 2022 Aug; 13(4):e0126722. PubMed ID: 35913160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory Th17 cell-mediated protection against lethal secondary pneumococcal pneumonia following influenza infection.
    Li Y; Yang Y; Chen D; Wang Y; Zhang X; Li W; Chen S; Wong SM; Shen M; Akerley BJ; Shen H
    mBio; 2023 Aug; 14(4):e0051923. PubMed ID: 37222516
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of IL-27 in susceptibility to post-influenza Staphylococcus aureus pneumonia.
    Robinson KM; Lee B; Scheller EV; Mandalapu S; Enelow RI; Kolls JK; Alcorn JF
    Respir Res; 2015 Feb; 16(1):10. PubMed ID: 25651926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-Streptococcus pneumoniae coinfection.
    Ellis GT; Davidson S; Crotta S; Branzk N; Papayannopoulos V; Wack A
    EMBO Rep; 2015 Sep; 16(9):1203-18. PubMed ID: 26265006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immune responses at the asymptomatic stage of influenza A viral infections of Streptococcus pneumoniae colonized and non-colonized mice.
    Cuypers F; Schäfer A; Skorka SB; Surabhi S; Tölken LA; Paulikat AD; Kohler TP; Otto SA; Mettenleiter TC; Hammerschmidt S; Blohm U; Siemens N
    Sci Rep; 2021 Oct; 11(1):20609. PubMed ID: 34663857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.
    Kang MC; Choi DH; Choi YW; Park SJ; Namkoong H; Park KS; Ahn SS; Surh CD; Yoon SW; Kim DJ; Choi JA; Park Y; Sung YC; Lee SW
    J Virol; 2015 Dec; 90(5):2273-84. PubMed ID: 26656713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-4 protects mice against lethal influenza and Streptococcus pneumoniae co-infected pneumonia.
    Peng Y; Wang X; Wang H; Xu W; Wu K; Go X; Yin Y; Zhang X
    Clin Exp Immunol; 2021 Sep; 205(3):379-390. PubMed ID: 34061992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.
    Wu Y; Tu W; Lam KT; Chow KH; Ho PL; Guan Y; Peiris JS; Lau YL
    J Virol; 2015 Feb; 89(4):2013-23. PubMed ID: 25428873
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Sharma-Chawla N; Stegemann-Koniszewski S; Christen H; Boehme JD; Kershaw O; Schreiber J; Guzmán CA; Bruder D; Hernandez-Vargas EA
    Front Immunol; 2019; 10():1864. PubMed ID: 31474978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection with influenza virus induces IL-33 in murine lungs.
    Le Goffic R; Arshad MI; Rauch M; L'Helgoualc'h A; Delmas B; Piquet-Pellorce C; Samson M
    Am J Respir Cell Mol Biol; 2011 Dec; 45(6):1125-32. PubMed ID: 21642589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza A Virus Infection Predisposes Hosts to Secondary Infection with Different Streptococcus pneumoniae Serotypes with Similar Outcome but Serotype-Specific Manifestation.
    Sharma-Chawla N; Sender V; Kershaw O; Gruber AD; Volckmar J; Henriques-Normark B; Stegemann-Koniszewski S; Bruder D
    Infect Immun; 2016 Dec; 84(12):3445-3457. PubMed ID: 27647871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal conjugate vaccine modulates macrophage-mediated innate immunity in pneumonia caused by Streptococcus pneumoniae following influenza.
    Mimura K; Kimura S; Kajiwara C; Nakakubo S; Schaller MA; Ishii Y; Standiford TJ; Kunkel SL; Tateda K
    Microbes Infect; 2020 Sep; 22(8):312-321. PubMed ID: 31958572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Respiratory Microbiomes, Plasma Metabolites, and Immune Responses in Influenza A Virus and Methicillin-Resistant Staphylococcus aureus Coinfection.
    Chen Q; Liu M; Guo H; Wang K; Liu J; Wang Y; Lin Y; Li J; Li P; Yang L; Jia L; Yang J; Li P; Song H
    Microbiol Spectr; 2023 Aug; 11(4):e0524722. PubMed ID: 37318361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1 Signaling Prevents Alveolar Macrophage Depletion during Influenza and
    Bansal S; Yajjala VK; Bauer C; Sun K
    J Immunol; 2018 Feb; 200(4):1425-1433. PubMed ID: 29311363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.